At what enterprise value was ARMONEA acquired in 2019?

During the acquisition of ARMONEA by COLISÉE in 2019, the transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b EUR.

What was the EV/EBITDA of ARMONEA when it was acquired by COLISÉE?

The estimated EV/EBITDA multiple for ARMONEA is in the range of 10x - 18x.

When was ARMONEA acquired by COLISÉE?

ARMONEA was acquired by COLISÉE in 2019.

What was the EBITDA of ARMONEA during the acquisition?

ARMONEA's EBITDA is estimated to be in the range of 25M - 50M EUR.

How is the data for the ARMONEA acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the ARMONEA deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.lejournaldesentreprises.com/article/le-groupe-colisee-change-dechelle-139061

← DATABASE

Home Database Healthcare & PharmaARMONEA

04/2019

ARMONEA acquired by COLISÉE

BELGIUM Health Providers / Healthcare Facilities / Nursing Homes EV 500M - 1.5b EUR

Context

Colisée Group entered into a definitive agreement to acquire 100% of Armonea to create the fourth-largest elderly care operator in Europe. This transformative acquisition doubled Colisée’s size, resulting in a combined entity with a turnover of approximately €1 billion and a network of 270 facilities across five countries. The merger was strategically designed to capitalize on geographic complementarities, merging Colisée’s strong Mediterranean presence with Armonea’s market leadership in Northern Europe. The transaction allowed the founder’s holding company, Jade, to maintain its role as a key minority shareholder with a 19% stake in the newly enlarged group.

ARMONEA, which reported an EBITDA margin of in 2018, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Armonea stands as the leading independent provider of elderly care in Belgium, specializing in the management of nursing homes, service flats, and residential care centers. At the time of the transaction, the group maintained a robust European footprint with operations extending into Spain and Germany, supported by a workforce of approximately 6,500 employees. The organization was recognized for its high standards of clinical care and residential hospitality, serving over 17,500 residents across its specialized network.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2018

2017

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
07/2019	I SQUARED CAPITAL / UI INVESTISSEMENT / BNP PARIBAS DEVELOPPEMENT	DOMIDEP	FRANCE	Nursing Homes
07/2019	NAXICAP PARTNERS / ARDIAN	EMERA	FRANCE	Nursing Homes
03/2019	DOMUSVI	RESIDALYA	FRANCE	Nursing Homes
01/2019	HUMANA	CORONARIA HOIVA	FINLAND	Nursing Homes
04/2018	INVESTINDUSTRIAL	LIFEBRAIN	ITALY	Labs (Biology)
03/2018	ICV PARTNERS	OUTPATIENT IMAGING AFFILIATES	UNITED STATES	Radiology
03/2018	THE ADOLFSEN GROUP	FRÖSUNDA	SWEDEN	Healthcare Facilities
01/2018	PERMIRA	I-MED RADIOLOGY NETWORK	AUSTRALIA	Radiology
06/2017	ICG / MANAGEMENT & PRIVATE INVESTORS	DOMUSVI	FRANCE	Nursing Homes
04/2017	EQT PARTNERS	COLISÉE	FRANCE	Nursing Homes

REFERENCES

Valuation range: EV 500M - 1.5b EUR

EBITDA range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ARMONEA by COLISÉE are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.